Objectives: To study whether geriatric patients with mild-to-moderate hyponatremia (≤131 mmol/l) reveal different outcomes in structured tests for functional and cognitive impairments, depression and malnutrition compared to normonatremic patients. Design: Single-center, retrospective case control study. Setting: The study was conducted in a Geriatric Evaluation and Management Unit of a Department for Geriatrics and Internal Medicine. Methods and Participants: We included 2,880 elderly patients (75.6% female, mean age 78.6 ± 6.98 years), consecutively admitted to the GEMU primarily or from another hospital or emergency department. Results were compared between a group of 129 patients with mild-to-moderate hyponatremia (118–131 mmol/l) and an age- and sex-matched control group of 129 patients with normal serum sodium values (>135 mmol/l). To assess functional and cognitive status, depression and malnutrition we used standardized tests of a geriatric assessment. Results: 16.7% (n = 477) of the total 2,880 patients were hyponatremic (≤135 mmol/l), 4.5% (n = 129) revealed moderate hyponatremia. Compared to the control group, these patients had significantly worse results in all tests of the Geriatric Assessment, including Activities of Daily Living, Mini Mental State Examination, Clock Completion Test, Geriatric Depression Score, Tinetti Mobility Test and the Timed Up&Go Test and the Mini Nutritional Assessment. Comorbidities were assessed by the Charlson Comorbidity Index and the Cumulative Illness Rating Scale with no significant difference between the two groups. The hyponatremic patients received significantly more medications than the normonatremic control group, but we could not find a significant difference with respect to the use of a distinct single drug therapy. Conclusion: We were able to demonstrate that geriatric patients with mild-to-moderate hyponatremia revealed a significantly worse outcome in all standardized tests of the geriatric assessment compared to a normonatremic control group. Serum sodium levels should therefore be considered when interpreting common tests of geriatric assessment.

Keywords:
Hyponatremia, Geriatric assessment, Geriatric patients, Impairment
1.
Renneboog B, Musch W, Vandemergel X, et al: Mild chronic hyponatremia is associated with falls, unsteadiness and attention deficits. Am J Med 2006;119:71.e1–e8.
2.
Passare G, Viitanen M, Törring O, et al: Sodium and potassium disturbances in the elderly: prevalence and association with drug use. Clin Drug Invest 2004;24:535–544.
3.
Vaidya C, Ho W, Freda BJ: Management of hyponatremia: providing treatment and avoiding harm. Cleve Clin J Med 2010;77:715–726.
4.
Thompson CJ: Hyponatremia: new association and new treatments. Eur J Endocrinol 2010;162(suppl 1):S1–S3.
5.
Adrogue HJ, Madias NE: Hyponatremia. N Engl J Med 2000;342:1581–1589.
6.
Decaux G: Is asymptomatic hyponatremia really asymptomatic? Am J Med 2006;119:S79–S82.
7.
Kinsella S, Moran S, Sullivan MO, et al: Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol 2010;5:275–280.
8.
Sandhu HS, Gilles E, DeVita MV, et al: Hyponatremia associated with large-bone fracture in elderly patients. Int Urol Nephrol 2009;41:733–737.
9.
Hoorn EJ, van der Lubbe N, Zietse R: SIADH and hyponatremia: why does it matter. NDT Plus 2009;2(suppl 3):iii5–iii11.
10.
Arányi Z, Kovács T, Szirmai I, et al: Reversible nerve conduction slowing in hyponatremia. J Neurol 2004;251:1532–1533.
11.
American Geriatrics Society, British Geriatrics Society, American Academy of Orthopedic Surgeons Panel on Falls Prevention: Guideline for the prevention of falls in older persons. J Am Geriatr Soc 2001;49:664–672.
12.
Liamis G, Milionis H, Elisaf M: A review of drug-induced hyponatremia. Am J Kidney Dis 2008;52:144–153.
13.
Vaidya C, Ho W, Freda BJ: Management of hyponatremia: providing treatment and avoiding harm. Cleve Clin J Med 2010;77:715–726.
14.
Liamis G, Milionis H, Elisaf M: Blood pressure drug therapy and electrolyte disorders. Int J Clin Pract 2008;62:1572–1580.
15.
Smith JM: Clinical implications of treating depressed older adults with SSRIs: possible risk of hyponatremia. J Gerontol Nurs 2010;36:22–27.
16.
Mannesse CK, van Puijenbroek EP, Jansen PA, van Marum RJ, Souverein PC, Egberts TC: Hyponatremia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase. Drug Saf 2010;33:569–578.
17.
Buggy Y, Layton D, Fogg C, Shakir S: Safety profile of oxacarbazepine: results from a prescription-event monitoring study. Epilepsia 2010;51:818–829.
18.
Dong X, Leppik I, White J: Hyponatremia from oxacarbazepine and carbamazepine. Neurology 2005;65;1976.
19.
Tsiropolous I, Andersen M, Hallas J: Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf 2009;18:483–491.
20.
Sarret D, Le Berre JP, Zemraoui N: Tramadol-induced hyponatremia. Am J Kidney Dis 2008;52:1026.
21.
Ellis G, Whitehead MA, Robinson D, O’Neill D, Langhorne P: Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomized controlled trials. BMJ 2011;343:d6553.
22.
Ellis G, Langhorne P: Comprehensive geriatric assessment for older hospital patients. Br Med Bull 2004;71:45–59.
23.
Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373–383.
24.
Salvi F, Miller MD, Grilli A, et al: A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients. J Am Geriatr Soc 2008;56:1926–1931.
25.
Hudon C, Fortin M, Soubhi H: Abbreviated guidelines for scoring the Cumulative Illness Rating Scale (CIRS) in family practice. J Clin Epidemiol 2007;60:212.
26.
Talasz H, Jansen SC, Kofler M, Lechleitner M: High prevalence of pelvic muscle dysfunction in hospitalized elderly woman with urinary incontinence. Int Urogynecol J 2012, DOI 10.1007/s00192-011-1628–3.
27.
Mahoney FI, Barthel DW: Functional evaluation: the Barthel index. Md State Med J 1965;14:61–65.
28.
Folstein MF, Folstein SE, McHugh PR, et al: ‘Mini-mental state’: a practical method for grading the cognitive status of patients for the clinicians. J Psychiatr Res 1975;12:189–198.
29.
Watson YI, Arfken CL, Birge SJ: Clock completion: an objective screening test for dementia. J Am Geriatr Soc 1993;41:1235–1240.
30.
Warshw GA, Moore JT, Friedmann SW, et al: Functional disability in the hospitalized elderly. JAMA 1982;248:847–850.
31.
Yesavage JA, Brink TL, Rose TL, et al: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37–49.
32.
Tinetti ME: Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 1986;34:119–126.
33.
Podsiadlo D, Richardson S: The timed ‘up and go’: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142–148.
34.
Guigoz Y, Garry JP: Mini nutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients. Facts Res Gerontol 1994, pp 15–59.
35.
Epstein M: Ageing and the kidney. J Am Soc Nephrol 1996;7:1106–1122.
36.
Gianelli S, Patel K, Windham BG, et al: Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc 2007;55:816–823.
37.
Rosholm JU, Nybo H, Anderson Ranberg K, Himmelstrup B, Skjelbo E, Christensen K, Gram LF: Hyponatremia in very old nonhospitalised people: association with drug use. Drugs Aging 2002;19:685–693.
38.
Passare G, Viitanen M, Törring O, Winblad B, Fastbom J: Sodium and potassium disturbances in the elderly: prevalence and association with drug use. Clin Drug Invest 2004;24:535–544.
39.
Onder G, Petrovic M, Tangiisuran B, et al: Development and Validation of a Score to Assess Risk of Adverse Drug Reactions Among In-Hospital Patients 65 Years or Older: The GerontoNet ADR Risk Score Arch Intern Med 2010;170:1142–1148.
40.
Greenberg A, Lehrich RW: Treatment of chronic hyponatremia: now we know how, but do we know when or if? J Am Soc Nephrol 2010;21:552–555.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.